Several Indian pharmaceutical companies, including Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Cipla, Mankind pharma, Ajanta Pharma, Sun Pharmaceutical Industries are expected to launch generic semaglutide injections
This medication acts as a dual GIP and GLP-1 receptor agonist, working to stabilize blood sugar and possibly influencing weight
Whilst these effects are usually mild to moderate and often improve over time, understanding why they occur, how to manage them, and when to seek medical advice is essential for safe and effective treatment
Semaglutide is an excellent option as well but ultimately it goes to who wants to be catered as the weight loss injections are now serving as a primary resource which helps in cutting weight, improving the quality of life and ultimately the Semaglutide and Tirzepatide are responsible for the weight loss however,, it is in conjunction with the physical activity which can include cardio, weight lifting, or daily routine exercise or the fixing of diet through eating the right food which includes the carbs, protein and other essential vitamins
